四磨汤与瘅胃散治疗糖尿病性胃轻瘫的疗效

发布时间：2018-01-08 03:17

本文关键词：四磨汤与瘅胃散治疗糖尿病性胃轻瘫的疗效　出处：《基因组学与应用生物学》2017年05期 　论文类型：期刊论文

【摘要】：研究四磨汤联合瘅胃散治疗脾虚气滞型糖尿病性胃轻瘫患者胃肠功能障碍的临床效果。本研究选取2013年8月至2015年8月我院接诊的60例脾虚气滞型糖尿病性胃轻瘫患者。按随机数表法分为观察组和对照组,给予对照组采取瘅胃散治疗,观察组在对照组的基础上加用四磨汤治疗,观察两组患者治疗后血糖水平、临床症状及疗效的改善效果。通过相关分析表明治疗后,观察组FPG、2hPG(6.84±1.20,8.85±1.50)mmol/L小于对照组(8.21±1.10,11.03±1.30)mmol/L,HbAlc(7.08±1.25)%小于对照组(8.87±1.30)%差异具有统计学意义(p0.05);观察组早饱、腹胀、恶心、呕吐、厌食、便秘腹泻交作、舌象改善时间(1.05±0.35,1.03±0.32,0.76±0.14,0.65±0.14,0.80±0.26,0.62±0.15,0.87±0.10)周均小于对照组(1.56±0.32,1.46±0.36,0.92±0.26,0.72±0.22,1.20±0.28,0.87±0.18,10.13±0.29)周差异具有统计学意义(p0.05);观察组MDA(2.53±0.75)nmol/L小于对照组(3.12±0.80)nmol/L;IL-6(26.28±3.26)pg/mL小于对照组(35.12±3.01)pg/m L;CPR(2.21±0.29)mg/L小于对照组(4.59±1.18)mg/L差异具有统计学意义(p0.05);观察组临床疗效96.66%(29/30)优于对照组70.00%(21/30)差异具有统计学意义(p0.05)。研究结果表明,四磨汤联合瘅胃散对改善脾虚气滞型糖尿病性胃轻瘫患者胃肠功能障碍疗效显著,值得临床推广。
[Abstract]:To study the clinical effect of Simo decoction combined with Dangwei Powder on gastrointestinal dysfunction in patients with diabetic gastroparesis with spleen deficiency and qi stagnation. This study selected 60 cases of spleen deficiency qi stagnation from August 2013 to August 2015 in our hospital. Patients with type type diabetic gastroparesis were randomly divided into observation group and control group. The control group was treated with Dangwei Powder, the observation group was treated with Simo decoction on the basis of the control group, and the blood glucose level of the two groups was observed after treatment. Correlation analysis showed that after treatment, the observation group FPG 2hPGN 6.84 卤1.20. 8.85 卤1.50 mmol / L was lower than that of control group (8.21 卤1.10g / L, 11.03 卤1.30g / L). The difference of HbAlc(7.08 卤1.25% was significantly lower than that of control group (8.87 卤1.30%). In the observation group, the time of early satiety, abdominal distension, nausea, vomiting, anorexia, constipation and diarrhea was 1.05 卤0.35 卤1.03 卤0.32 卤0.76 卤0.14. 0.65 卤0.14g 0.80 卤0.26g 0.62 卤0.15U 0.87 卤0.10) weeks were smaller than those of the control group 1.56 卤0.32U 1.46 卤0.36. The difference of 0.92 卤0.26g 0.72 卤0.22U 1.20 卤0.28U 0.87 卤0.18U 10.13 卤0.29) weeks was statistically significant (P 0.05). The MDA(2.53 卤0.75 nmol / L in the observation group was lower than that in the control group (3.12 卤0.80 nmol / L). IL-6(26.28 卤3.26 g / mL was lower than that of the control group (35.12 卤3.01 渭 g / mL). The difference of CPR(2.21 卤0.29 mg / L was significantly lower than that of control group (4.59 卤1.18 mg / L). The clinical curative effect of the observation group was 96.6666 / 29 / 30), which was better than that of the control group (70.0021 / 30). The difference was statistically significant (p 0.05). The results showed that there was no significant difference between the two groups. The effect of Simo decoction combined with Dangwei Powder on improving gastrointestinal dysfunction in patients with diabetic gastroparesis due to spleen deficiency and qi stagnation is significant and worthy of clinical promotion.
【作者单位】：昆明市延安医院中医科;昆明市红云医院;
【基金】：四川省中医药管理局科研项目(2012CP30) 四川省教育厅科技计划项目(16ZB0535)共同资助
【分类号】：R259
【正文快照】： *通讯作者,773069744@qq.comThe Curative Effect of Simotang and Gastric Powder on Treatment ofDiabetic GastroparesisZhang Baoguo1*Xu Lirong21 Department of traditional Chinese medicine,Yanan hospital,Kunming,650051;2 Hongyun hospital of Kunming city,Kunmin

【相似文献】